{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:46:51Z","timestamp":1793497611210,"version":"4.5.0"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The systemic immune-inflammation index (SII), derived from peripheral blood parameters, has emerged as a novel marker reflecting the balance between host immunity and tumor-related inflammatory burden. This study aimed to investigate the prognostic impact of baseline SII on survival outcomes in patients with gastric or gastroesophageal junction (GEJ) cancer undergoing perioperative FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy. Materials and Methods: In this retrospective study, 168 patients with histologically confirmed gastric or GEJ cancer who received perioperative FLOT therapy were included. SII was calculated using the formula: SII = (Platelets \u00d7 Neutrophils)\/Lymphocytes. ROC curve analysis determined the optimal SII cutoff for predicting mortality. Patients were categorized into low (SII \u2264685) and high (SII &gt;685) groups. Overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan\u2013Meier analysis and compared via the log-rank test. Cox proportional hazards regression models were used for univariate and multivariate analysis. Results: The optimal cutoff value for SII was determined to be 685 (AUC: 0.652, 95% CI: 0.558\u20130.747, p = 0.003). High SII was significantly shorter OS (17.4 vs. 28.2 months, p = 0.001) Multivariate analysis identified high SII (HR = 1.88, 95% CI: 1.36\u20132.89, p = 0.039), advanced T stage (HR = 3.693, p &lt; 0.001), poor treatment response (HR = 0.36, p &lt; 0.001), and ECOG-PS \u22651 (HR = 3.297, p &lt; 0.001) as independent predictors of mortality. Conclusions: Elevated baseline SII is an independent predictor of worse OS and DFS in gastric and GEJ cancer patients receiving perioperative FLOT chemotherapy. SII may serve as a practical and inexpensive biomarker to support risk stratification and personalized treatment decisions.<\/jats:p>","DOI":"10.3390\/medicina61091614","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:06:32Z","timestamp":1757318792000},"page":"1614","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Systemic Immune-Inflammation Index as a Prognostic Marker in Gastric and Gastroesophageal Junction Cancers Receiving Perioperative FLOT Therapy"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8769-1584","authenticated-orcid":false,"given":"Pinar","family":"Peker","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Adana City Training and Research Hospital, Adana 01370, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6942-9858","authenticated-orcid":false,"given":"Asli","family":"Ge\u00e7gel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir 35100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-7775","authenticated-orcid":false,"given":"O\u011fuzcan","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine, Ege University, Izmir 35100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"G\u00f6kmen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mehmet Akif Ersoy Public Hospital, \u00c7anakkale 17100, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Menekse","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Manisa City Hospital, Manisa 45040, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2994-9191","authenticated-orcid":false,"given":"Alpay","family":"Du\u015fgun","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adana City Training and Research Hospital, Adana 01370, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna Bozkurt","family":"Duman","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adana City Training and Research Hospital, Adana 01370, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5033-1479","authenticated-orcid":false,"given":"Timu\u00e7in","family":"\u00c7il","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Adana City Training and Research Hospital, Adana 01370, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: A comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: Molecular mechanisms and interventional targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10875-012-9847-0","article-title":"Cancer-related inflammation","volume":"33","author":"Candido","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK Biobank","volume":"36","author":"Borch","year":"2021","journal-title":"Eur. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e22964","DOI":"10.1002\/jcla.22964","article-title":"Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab","volume":"33","author":"Liu","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.21037\/jgo.2019.05.03","article-title":"The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer","volume":"10","author":"Wang","year":"2019","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Malik, M., Iqbal, S., Inayat, N., Ali, A., Irfan, M., Arif, A., Abbas, N., Syed, A.A., Rasheed, H., and Afzal, M. (2024). Predictive and Prognostic Role of Systemic Immune-Inflammation Index (SII) in Metastatic Colorectal Cancer Patients Treated with Trifluridine\/Tipiracil. Biomedicines, 12.","DOI":"10.3390\/biomedicines12092076"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1759-7714.12995","article-title":"Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Thorac. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","article-title":"Inflammation: The incubator of the tumor microenvironment","volume":"8","author":"Denk","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Qiu, Y., Zhang, Z., and Chen, Y. (2021). Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.537140"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: Treat the tumour and treat the host","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12957-021-02286-3","article-title":"Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer","volume":"19","author":"Inoue","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40880-017-0243-2","article-title":"Prognostic value of systemic immune-inflammation index in patients with gastric cancer","volume":"36","author":"Wang","year":"2017","journal-title":"Chin. J. Cancer."},{"key":"ref_18","first-page":"24","article-title":"Does systemic immune inflammation index have predictive value in gastric cancer prognosis?","volume":"10","author":"Uzunoglu","year":"2023","journal-title":"N. Clin. Istanb."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, X., Luo, Y., Xu, J., Zhao, J., Zeng, Y., Zhang, Y., Xu, Z., and Li, Q. (2022). The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis. Front. Surg., 9.","DOI":"10.3389\/fsurg.2022.922595"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3892\/etm.2024.12410","article-title":"Systemic immune inflammation index and gastric cancer prognosis: A systematic review and meta-analysis","volume":"27","author":"Yang","year":"2024","journal-title":"Exp. Ther. Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Xiang, S., Zhao, L., Xiao, Z., Li, J., Huang, R., Liu, H., Xu, H., Xie, Y., Ma, Y., and Lin, R. (2023). Prognostic value of systemic immune inflammation index and geriatric nutrition risk index in early-onset colorectal cancer. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1134300"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Meza-Valderrama, D., Anaya-Loyola, J.A., Garc\u00eda-Morales, J.M., Gallegos-Cabriales, N.I., Navarro-Navarro, J.F., Enciso-Vargas, J.A., S\u00e1nchez-Ram\u00edrez, S., Hern\u00e1ndez-Cort\u00e9s, M., Bernal-Orozco, J.A., and Padilla-Romo, A.L. (2021). Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer. Nutrients, 13.","DOI":"10.3390\/nu13030761"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.21037\/jgo-20-252","article-title":"Prognostic value of systemic immune-inflammatory index in survival outcome in gastric cancer: A meta-analysis","volume":"12","author":"Fu","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e5886","DOI":"10.1097\/MD.0000000000005886","article-title":"Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus","volume":"96","author":"Feng","year":"2017","journal-title":"Medicine"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Wang, H., Wang, J., Wang, Z., Li, Y., Bai, Z., Bei, J., Jin, J., Ye, G., and Wang, L. (2020). Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component. Biomed. Res. Int., 2020.","DOI":"10.1155\/2020\/5038217"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1787424","DOI":"10.1155\/2018\/1787424","article-title":"Nomogram Based on Systemic Immune-Inflammation Index to Predict Overall Survival in Gastric Cancer Patients","volume":"2018","author":"Shi","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/jcsm.13095","article-title":"Associations between body mass index, weight loss and overall survival in patients with advanced lung cancer","volume":"13","author":"Oswalt","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4111\/icu.20240052","article-title":"Impact of pretreatment body mass index on clinical outcomes in patients with metastatic renal cell carcinoma receiving first-line immune checkpoint inhibitor-based therapy: A systematic review and meta-analysis","volume":"65","author":"Lee","year":"2024","journal-title":"Investig. Clin. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.ejso.2018.09.007","article-title":"Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis","volume":"44","author":"Zhao","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrendo.2014.94","article-title":"Obesity and cancer\u2014mechanisms underlying tumour progression and recurrence","volume":"10","author":"Park","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer","volume":"34","author":"Versteeg","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1097\/JS9.0000000000000741","article-title":"Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: A retrospective cohort study","volume":"109","author":"Wu","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2147\/JIR.S404585","article-title":"Nomogram Based on Preoperative Fibrinogen and Systemic Immune-Inflammation Index Predicting Recurrence and Prognosis of Patients with Borrmann Type III Advanced Gastric Cancer","volume":"16","author":"Wang","year":"2023","journal-title":"J. Inflamm. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.21873\/invivo.13657","article-title":"The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment","volume":"38","author":"Aoyama","year":"2024","journal-title":"In Vivo"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cpt.789","article-title":"Cancer-Related Systemic Inflammation: The Challenges and Therapeutic Opportunities for Personalized Medicine","volume":"102","author":"Shinko","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12957-023-02887-0","article-title":"Predictive significance of surgery-induced lymphopenia on the survival after curative resection for locally advanced gastric cancer: A retrospective cohort analysis","volume":"21","author":"Aizawa","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.2147\/CMAR.S378768","article-title":"The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy","volume":"14","author":"Jan","year":"2022","journal-title":"Cancer Manag. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, P.-X., Wei, X.-L., Liu, Y., Jiang, W.-Q., Xu, R.-H., Luo, H.-Y., Qiu, M.-Z., Wang, F.-H., Wang, D.-S., and Zhou, Z.-W. (2021). A nomogram combining plasma fibrinogen and systemic immune-inflammation index predicts survival in patients with resectable gastric cancer. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-89648-9"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1614\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:21Z","timestamp":1760035281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/9\/1614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["medicina61091614"],"URL":"https:\/\/doi.org\/10.3390\/medicina61091614","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]}}}